Single-center, single-arm exploratory trial of Deucravacitinib in the treatment of refractory localized scleroderma

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 972ecbb4ed73c4d0663becc8006775d62b9ac943
First added on: Oct 10, 2026